TMVR Market - Medtronic, Abbott Laboratories, Inc & Edward Lifesciences Corporation Lead Transcatheter Mitral Valve Replacement Industry
PR Newswire Europe - Wed Aug 03, 11:45AM CDT
PUNE, India, August 3, 2016 /PRNewswire/ --
ABT: 44.95 (-0.12), MDT: 86.67 (-0.97)
Medical Industry Week Issue - R&D, Product, Financial, Agreement and Corporate News - Research and Markets
BusinessWire - Wed Aug 03, 4:55AM CDT
Research and Markets has announced the addition of the "Medical Industry Week Issue" newsletter to their offering.
MDT: 86.67 (-0.97)
Penumbra (PEN) to Report Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:23PM CDT
Penumbra, Inc. (PEN) is expected to report its second-quarter 2016 financial numbers on Aug 9.
MDT: 86.67 (-0.97), ANIP: 62.10 (+1.08), ALQA: 1.10 (-0.02), PEN: 67.21 (-1.20)
Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020) - Dominated by DexCom Inc. & Medtronic - Research and Markets
BusinessWire - Tue Aug 02, 9:53AM CDT
Research and Markets has announced the addition of the "Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)" report to their offering.
MDT: 86.67 (-0.97)
Medtronic CoreValve(TM) Evolut(TM) R System First TAVI to Receive CE Mark for Intermediate Risk Aortic Stenosis Patients
Globe Newswire - Mon Aug 01, 10:00AM CDT
Next-Generation Recapturable Device is the First-of-its-Kind Approved in Europe to Treat Intermediate Risk Patients as an Alternative to Open-Heart Surgery
MDT: 86.67 (-0.97)
Wearable Devices Market Continues to Show Strength
PR Newswire Europe - Mon Aug 01, 8:01AM CDT
NEW YORK, August 1, 2016 /PRNewswire/ --
FIT: 14.93 (+1.77), GPRO: 13.30 (+0.75), MDT: 86.67 (-0.97), GRMN: 55.46 (+0.60)
Global ENT Market Worth 15.5 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Widex, Medtronic, Siemens Healthcare - Research and Markets
BusinessWire - Fri Jul 29, 4:39AM CDT
Research and Markets has announced the addition of the "Global ENT Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022" report to their offering.
MDT: 86.67 (-0.97)
HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue
PR Newswire - Thu Jul 28, 7:00AM CDT
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced total revenue of $68.7 million for the quarter ended June 30, 2016, compared to $73.6 million for the same period in 2015 and $55.1 million for the first quarter of 2016. Total revenue decreased approximately 7% year-over-year, which is primarily attributable to the third quarter 2015 completion of enrollment of the company's ENDURANCE2 Destination Therapy (DT) clinical trial, which contributed approximately $5 million to revenue in the second quarter of 2015.
MDT: 86.67 (-0.97), HTWR: 57.94 (+0.05)
REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment
Globe Newswire - Wed Jul 27, 2:15PM CDT
VIVA Sponsored REALITY Study Assessing Vessel Preparation and Treatment in Severe Calcified Lesions Expands to Germany; Principal Investigators Named; First Patient Enrolled
MDT: 86.67 (-0.97)
Medtronic Expands Continuous Glucose Monitoring (CGM) Solutions for People with Diabetes Using Insulin Injections with CE Mark Receipt
Globe Newswire - Tue Jul 19, 8:01AM CDT
New Guardian(TM) Connect System Will Be Launched in Q2 FY17 Outside the U.S.
MDT: 86.67 (-0.97)
Medtronic Receives FDA Approval for Two-Level Prestige LP(TM) Cervical Disc Procedures
Globe Newswire - Mon Jul 18, 8:01AM CDT
Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion
MDT: 86.67 (-0.97)
BRIC Clot Management Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, Teleflex, Terumo Corp - Research and Markets
BusinessWire - Fri Jul 15, 2:42PM CDT
Research and Markets has announced the addition of the "BRIC Clot Management Devices Market Outlook to 2021" report to their offering.
MDT: 86.67 (-0.97)
Medtronic's IN.PACT Admiral DCB Wins FDA Nod for 150 mm
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 6:22AM CDT
With Medtronic (MDT)being a major player in the medical devices market, surely the FDA approval will accelerate the demand for its peripheral therapy products.
BSX: 23.84 (-0.33), MDT: 86.67 (-0.97), GWPH: 95.02 (+0.95), NUVA: 62.76 (+0.13)
Global Cardiology Electrodes Market Growth of 2.61% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: ConMed, Medtronic, Bio-Protech - Research and Markets
BusinessWire - Fri Jul 15, 5:30AM CDT
Research and Markets has announced the addition of the "Global Cardiology Electrodes Market 2016-2020" report to their offering.
MDT: 86.67 (-0.97)
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 8:30AM CDT
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
ABT: 44.95 (-0.12), SNN: 33.20 (-0.28), JNJ: 123.90 (-0.95), MDT: 86.67 (-0.97), STJ: 83.53 (+0.01)
MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 118.58 (-0.33), LDRH: 36.98 (-0.02), MDT: 86.67 (-0.97), PAHC: 21.02 (+0.05), MLAB: 105.13 (-3.14), NUVA: 62.76 (+0.13), BSX: 23.84 (-0.33), BABY: 38.40 (-0.05), SNN: 33.20 (-0.28), JNJ: 123.90 (-0.95), DXCM: 90.87 (-1.91), GWPH: 95.02 (+0.95), RMD: 68.80 (-0.58), WOOF: 70.57 (+0.87), ABT: 44.95 (-0.12), VIVO: 19.42 (+0.13), MASI: 53.18 (+0.64), TMO: 156.00 (-0.44), CYH: 12.39 (+0.19), HTWR: 57.94 (+0.05), FEIC: 106.60 (-0.05), ISRG: 687.73 (-2.76), CFMS: 6.95 (+0.12), STE: 70.64 (-0.12), STJ: 83.53 (+0.01), XRAY: 65.14 (+0.51), HOLX: 39.00 (-0.03)
Mazor Robotics Introduces Mazor X for Robotic Spine Surgery
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 8:19AM CDT
Mazor Robotics unveils a revolutionary platform for spine surgeries using highly automated robotic technologies.
ABMD: 118.58 (-0.33), MASI: 53.18 (+0.64), MDT: 86.67 (-0.97), MZOR: 23.37 (+0.77)